INNV vs MD

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 13, 2026

INNV

50.6
AI Score
VS
MD Wins

MD

50.8
AI Score

Investment Advisor Scores

INNV

51score
Recommendation
HOLD

MD

51score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric INNV MD Winner
Net Income -30.31M 69.42M MD
Operating Income -29.76M 98.58M MD
ROE -12.9% 7.9% MD
ROA -5.8% 3.3% MD
Total Assets 526.85M 2.13B MD
Cash 64.13M 288.88M MD
Debt/Equity 0.26 0.69 INNV
Current Ratio 1.07 1.32 MD

Relative Price Performance (Last 90 Days)

INNV 1M: -2.1% · 3M: +48.7% MD 1M: +3.9% · 3M: +23.3%

Current Technical Phase

INNV

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (15.3% over 20 days), RSI 51

RSI (14): 50.8 · Price: $10.96

MD

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (6.6% over 20 days), RSI 54

RSI (14): 53.9 · Price: $26.57

Fundamentals Snapshot

Metric INNV MD
Market Cap
Forward P/E 26.7 10.9
Trailing P/E 12.5
Revenue (TTM)
Revenue Growth 0.2% 0.0%
Gross Margin 0.7% 0.3%
Operating Margin -0.1% 0.1%
EPS -0.08 2.09
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, MD is currently the stronger investment candidate, winning 7 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.